Virtu KCG Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,000
Closed -$284K 3637
2015
Q4
$284K Sell
2,000
-100
-5% -$13.3K ﹤0.01% 2233
2015
Q3
$257K Buy
+2,100
New +$274K ﹤0.01% 2278
2015
Q1
Sell
-6,500
Closed -$814K 3870
2014
Q4
$814K Buy
6,500
+3,900
+150% +$474K 0.01% 1152
2014
Q3
$316K Sell
2,600
-600
-19% -$73K 0.01% 2293
2014
Q2
$378K Sell
3,200
-32,500
-91% -$3.82M 0.01% 2273
2014
Q1
$4.29M Buy
35,700
+24,600
+222% +$2.92M 0.05% 316
2013
Q4
$1.24M Buy
11,100
+3,600
+48% +$358K 0.01% 1017
2013
Q3
$691K Buy
+7,500
New +$678K 0.01% 1608

Other funds holding TMO

Virtu KCG Holdings's TMO Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Thermo Fisher Scientific (TMO) stake by 66% in Q2 2017, selling an estimated $2.87M and leaving 8,640 shares worth $1.51M. The position accounts for 0.04% of the portfolio, ranked #356.

Virtu KCG Holdings first reported a position in TMO in Q3 2013 and has held it in 15 quarters since. The position peaked at $5.88M in Q1 2014. 1,159 funds tracked by Wall St. Rank hold TMO as of Q2 2017.

  • Virtu KCG Holdings held 8,640 shares of Thermo Fisher Scientific worth $1.51M as of Q2 2017.
  • Virtu KCG Holdings sold 17,060 Thermo Fisher Scientific shares in Q2 2017, an estimated $2.87M.
  • Thermo Fisher Scientific made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #356 holding.
  • Virtu KCG Holdings first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Thermo Fisher Scientific position peaked at $5.88M in Q1 2014.
  • 1,159 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.